LC
NUS icon

Lindbrook Capital’s Nu Skin NUS Stock Holding History

Lindbrook Capital’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$16.1K Buy
2,222
+499
+29% +$3.63K ﹤0.01% 1451
2024
Q4 		$11.9K Buy
1,723
+1,377
+398% +$9.47K ﹤0.01% 1569
2024
Q3 		$2.55K Sell
346
-354
-51% -$3.31K ﹤0.01% 2272
2024
Q2 		$7.38K Buy
700
+495
+241% +$6.27K ﹤0.01% 1800
2024
Q1 		$2.83K Sell
205
-311
-60% -$4.86K ﹤0.01% 2120
2023
Q4 		$10K Buy
516
+89
+21% +$1.64K ﹤0.01% 1549
2023
Q3 		$9.06K Buy
427
+124
+41% +$3.22K ﹤0.01% 1465
2023
Q2 		$10.1K Sell
303
-17
-5% -$626 ﹤0.01% 1464
2023
Q1 		$12.6K Sell
320
-7
-2% -$291 ﹤0.01% 1304
2022
Q4 		$13.8K Buy
327
+3
+0.9% +$115 ﹤0.01% 1268
2022
Q3 		$11K Sell
324
-21
-6% -$874 ﹤0.01% 1284
2022
Q2 		$15K Buy
345
+183
+113% +$8.4K ﹤0.01% 1099
2022
Q1 		$8K Sell
162
-60
-27% -$2.97K ﹤0.01% 1390
2021
Q4 		$11K Buy
222
+60
+37% +$2.67K ﹤0.01% 1235
2021
Q3 		$7K Hold
162
– – ﹤0.01% 1137
2021
Q2 		$9K Hold
162
– – ﹤0.01% 1095
2021
Q1 		$9K Hold
162
– – ﹤0.01% 1064
2020
Q4 		$9K Hold
162
– – ﹤0.01% 959
2020
Q3 		$8K Hold
162
– – ﹤0.01% 920
2020
Q2 		$6K Sell
162
-55
-25% -$1.77K ﹤0.01% 1023
2020
Q1 		$5K Buy
217
+196
+933% +$5.9K ﹤0.01% 1004
2019
Q4 		$1K Buy
+21
New +$857 ﹤0.01% 1420

Other funds holding NUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Lindbrook Capital's NUS Position: Q1 2025 in Review

Lindbrook Capital increased its Nu Skin (NUS) stake by 29% in Q1 2025, buying an estimated $3.63K and bringing the position to 2,222 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

Lindbrook Capital first reported a position in NUS in Q4 2019 and has held it in 22 quarters since. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

  • Lindbrook Capital held 2,222 shares of Nu Skin worth $16.1K as of Q1 2025.
  • Lindbrook Capital bought 499 Nu Skin shares in Q1 2025, an estimated $3.63K.
  • Nu Skin made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1451 holding.
  • Lindbrook Capital first reported a position in Nu Skin in Q4 2019 and has held it in 22 quarters since.
  • 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.